Article info

Download PDFPDF
Genetic variants of NHEJ DNA ligase IV can affect the risk of developing multiple myeloma, a tumour characterised by aberrant class switch recombination
  1. Correspondence to:
 Professor G J Morgan, Academic Unit of Haematology and Oncology, University of Leeds, Algernon Firth Building, Leeds, West Yorkshire LS2 9JT, UK;
 garethm{at}pathology.leeds.ac.uk
View Full Text

Citation

Roddam PL, Rollinson S, O’Driscoll M, et al
Genetic variants of NHEJ DNA ligase IV can affect the risk of developing multiple myeloma, a tumour characterised by aberrant class switch recombination

Publication history

  • Accepted August 20, 2002
  • Revised August 20, 2002
  • First published December 1, 2002.
Online issue publication 
February 22, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.